Fig. 4
From: Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Tumor-to-blood and tumor-to-kidney 177Lu activity concentration ratios in NET xenograft models: CLB-BAR (present study), CLB-GE (present study), IMR-32 (present study), AR42J, GOT1, GOT2 and NCI-H69 at 1 h, 24 h and 168 h post injection with 177Lu-octreotate. The data for NB cell lines xenografts (CLB-BAR, CLB-GE and IMR-32) were compared with corresponding values for rat pancreatic tumor (AR42J*) small intestine neuroendocrine tumor (GOT1), medullary carcinoma (GOT2) and human small cell lung cancer (NCI-69) in nude mice. The activity injected is presented in parentheses. * indicates rat origin and of exocrine type. The other cells or cell lines are human